Kidney Medicine (Nov 2021)

Successful Use of Arteriovenous Graft for Hemodialysis Access After Left Ventricular Assist Device Placement

  • Katherine Toma,
  • Jacob S. Stevens,
  • Nicholas J. Morrissey,
  • Melana Yuzefpolskaya,
  • Jai Radhakrishnan,
  • S. Ali Husain

Journal volume & issue
Vol. 3, no. 6
pp. 1091 – 1094

Abstract

Read online

Kidney replacement therapy is required in up to one-third of patients after left ventricular assist device (LVAD) placement. A subset of these patients requires long-term maintenance hemodialysis and therefore needs durable vascular access but the ideal access in such patients has not been established. We present a series of 3 patients in whom arteriovenous grafts (AVGs) were successfully used for long-term kidney replacement therapy after LVAD placement. The maximum time from AVG placement to first successful AVG use was 40 days, and the longest AVG use duration was more than 2 years. 2 patients required AVG excision due to infection but both had successful placement of a second AVG. Total time on kidney replacement therapy was 993, 1,055, and 956 days for the 3 cases, of which dialysis catheter use was required for only 23%, 6.5%, and 27%, respectively. These cases suggest that AVG placement is a viable option for dialysis access in patients with LVADs.

Keywords